Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-05-16FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ALENDRONATE SODIUM tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., enabling a …
-
FDA approval · 2012-04-30FDA Approved: IBANDRONATE SODIUM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' ibandronate sodium as an original ANDA, enabling a generic product for osteoporosis in postmenopausal…
-
FDA approval · 2012-04-27FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for PROLIA (denosumab) filed by Amgen.
-
FDA approval · 2012-04-11FDA Approved: PREMARIN — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Premarin (conjugated estrogens) filed by Wyeth Pharmaceuticals, a Pfizer subsidiary. The submiss…
-
FDA approval · 2012-03-19FDA Approved: IBANDRONATE SODIUM — Original Application (Apotex Corp)
FDA approved the original application for ibandronate sodium by Apotex Corp, enabling a generic version of the osteoporosis treatment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-03-19FDA Approved: IBANDRONATE SODIUM — Original Application (Bionpharma Inc.)
FDA approved the original generic application for ibandronate sodium by Bionpharma Inc., enabling a generic version of the osteoporosis trea…
-
FDA approval · 2012-03-13FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
-
FDA approval · 2012-02-02FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PREMPRO (conjugated estrogens and medroxyprogesterone acetate) submitted by Wyeth Pharmaceutical…
-
FDA approval · 2011-10-28FDA Approved: CONJUGATED ESTROGENS — Supplemental Application (Prasco Laboratories)
FDA has approved a supplemental NDA for Conjugated Estrogens (Estrogens, Conjugated) from Prasco Laboratories.
-
FDA approval · 2011-08-22FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risedronate sodium) by Allergan, Inc.
-
FDA approval · 2011-08-22FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for Atelvia (risendronate sodium), resulting in an approved label-related update for the pr…
-
FDA approval · 2011-08-10FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide filed by Prasco Laboratories, expanding the regulatory status of the product un…
-
FDA approval · 2011-07-07FDA Approved: ALENDRONATE SODIUM — Supplemental Application (EXELAN PHARMACEUTICALS INC.)
FDA approved a supplemental application for alendronate sodium submitted by Exelan Pharmaceuticals.
-
FDA approval · 2011-07-01FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax Plus D (alendronate sodium and cholecalciferol) by Organon LLC.
-
FDA approval · 2011-04-06FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ALENDRONATE SODIUM from Aurobindo Pharma Limited, indicating approval of a supplemental submissi…
-
FDA approval · 2011-04-01FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium filed by Amneal Pharmaceuticals of New York LLC. This action updates the regu…
-
FDA approval · 2011-02-15FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Alendronate sodium filed by Aurobindo Pharma Limited.
-
FDA approval · 2011-01-25FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax Plus D (alendronate sodium with cholecalciferol) from Organon LLC.
-
FDA approval · 2011-01-25FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Atelvia (risendronate sodium), a delayed-release bisphosphonate, with updated label…
-
FDA approval · 2010-10-08FDA Approved: ATELVIA — Original Application (Allergan, Inc.)
FDA approved Atelvia (delayed-release risedronate sodium) under an original NDA from Allergan, for treatment of postmenopausal osteoporosis.
-
FDA approval · 2010-06-01FDA Approved: PROLIA — Original Application (Amgen, Inc)
The FDA approved PROLIA (denosumab) in its original application by Amgen, establishing its use for osteoporosis in postmenopausal women.
-
FDA approval · 2010-04-22FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ALENDRONATE SODIUM submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2009-12-30FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PREMPRO (conjugated estrogens and medroxyprogesterone acetate) filed by Wyeth Pharmaceutical…
-
FDA approval · 2009-07-23FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risendronate sodium) from Allergan, Inc., approving changes to the product labeling und…
-
FDA approval · 2009-05-18FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PREMPRO (conjugated estrogens and medroxyprogesterone acetate) from Wyeth Pharmaceuticals (Pfize…